![PAC1‐PAC2 proteasome assembly chaperone retains the core α4–α7 assembly intermediates in the cytoplasm - Wu - 2018 - Genes to Cells - Wiley Online Library PAC1‐PAC2 proteasome assembly chaperone retains the core α4–α7 assembly intermediates in the cytoplasm - Wu - 2018 - Genes to Cells - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/55cd5574-c6c6-4056-a362-fbe03f9e4fc1/gtc12631-toc-0001-m.jpg?trick=1678415141000)
PAC1‐PAC2 proteasome assembly chaperone retains the core α4–α7 assembly intermediates in the cytoplasm - Wu - 2018 - Genes to Cells - Wiley Online Library
![Signal transduction mechanisms for lung cancer PAC1. Activated PAC1... | Download Scientific Diagram Signal transduction mechanisms for lung cancer PAC1. Activated PAC1... | Download Scientific Diagram](https://www.researchgate.net/publication/221887161/figure/fig3/AS:305282061225987@1449796323703/Signal-transduction-mechanisms-for-lung-cancer-PAC1-Activated-PAC1-interacts-with-G.png)
Signal transduction mechanisms for lung cancer PAC1. Activated PAC1... | Download Scientific Diagram
Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential | ACS Chemical Biology
Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro | PLOS ONE
![Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies | British Journal of Cancer Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-02089-7/MediaObjects/41416_2022_2089_Fig1_HTML.png)
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies | British Journal of Cancer
![Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 - Full Text View - ClinicalTrials.gov Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 - Full Text View - ClinicalTrials.gov](https://www.clinicaltrials.gov/ct2/html/images/warning.png)
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 - Full Text View - ClinicalTrials.gov
![PACAP38 and PAC1 receptor blockade: a new target for headache? | The Journal of Headache and Pain | Full Text PACAP38 and PAC1 receptor blockade: a new target for headache? | The Journal of Headache and Pain | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs10194-018-0893-8/MediaObjects/10194_2018_893_Fig1_HTML.png)